Lupus anticoagulant-hypoprothrombinemia syndrome presenting with co-existing cerebral venous thrombosis and subdural hemorrhage

J Mal Vasc. 2016 Dec;41(6):403-406. doi: 10.1016/j.jmv.2016.07.003. Epub 2016 Oct 12.

Abstract

The lupus anticoagulant-hypoprothrombinemia syndrome (LA-HPS) - the association of acquired factor II deficiency and lupus anticoagulant - is a rare disease that may cause a predisposition not only to thrombosis but also to severe bleeding. We are reporting on a 36-year-old female patient presenting with co-existing cerebral venous thrombosis and subdural hemorrhage. The coagulation screening showed a prolonged prothrombin time (PT), activated partial thromboplastin time (aPTT), and a normal fibrinogen level and platelet count. Evaluation of the clotting factors revealed decreased levels of factors II (37%). Factors V, VIII, IX and XI were normal. Lupus anticoagulant (LA) was demonstrated by the Dilute Russell's Viper Venom Test (DRVVT). Immunological work-up was positive for IgG type anticardiolipines antibodies (aCL). Successful management consisted first of oral prednisone (60mg/d). Thus, anticoagulation was introduced once factor II had stabilized.

Keywords: Antiphospholipid syndrome; Hypoprothrombinemia; Hypoprothrombinémie; Lupus anticoagulant; Syndrome des antiphospholipides.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antiphospholipid Syndrome / complications
  • Cerebral Veins
  • Female
  • Hematoma, Subdural / complications
  • Hematoma, Subdural / diagnosis*
  • Humans
  • Hypoprothrombinemias / blood
  • Hypoprothrombinemias / diagnosis*
  • Hypoprothrombinemias / etiology
  • Intracranial Thrombosis / complications
  • Intracranial Thrombosis / diagnosis*
  • Lupus Coagulation Inhibitor / adverse effects
  • Lupus Coagulation Inhibitor / analysis*
  • Partial Thromboplastin Time
  • Prednisone / therapeutic use
  • Prothrombin / analysis
  • Prothrombin Time

Substances

  • Lupus Coagulation Inhibitor
  • Prothrombin
  • Prednisone

Supplementary concepts

  • Acquired hypoprothrombinemia